Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 19.97M P/E - EPS this Y 58.20% Ern Qtrly Grth -
Income -28.19M Forward P/E -0.74 EPS next Y 5.10% 50D Avg Chg -34.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -19.00%
Dividend N/A Price/Book 0.58 EPS next 5Y - 52W High Chg -52.00%
Recommedations 1.70 Quick Ratio 3.25 Shares Outstanding 30.88M 52W Low Chg 49.00%
Insider Own 18.06% ROA -65.99% Shares Float 23.67M Beta 1.18
Inst Own 36.16% ROE -142.45% Shares Shorted/Prior 402.97K/404.15K Price 0.94
Gross Margin - Profit Margin - Avg. Volume 87,761 Target Price 7.00
Oper. Margin - Earnings Date Nov 12 Volume 163,146 Change -7.84%
About Vincerx Pharma, Inc.

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. The company is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with relapsed and refractory leukemia and lymphoid malignancies, as well as solid tumors and non-Hodgkin lymphoma; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat advanced or metastatic solid tumors. Its product candidates also include VIP943 in Phase 1 clinical trials for the treatment of relapsed/refractory acute myeloid leukemia, myelodysplastic syndrome, and B-cell acute lymphoblastic leukemia; and VIP924 in preclinical studies for the treatment of B-cell malignancies. Vincerx Pharma, Inc. was founded in 2019 and is based in Palo Alto, California.

Vincerx Pharma, Inc. News
10/10/24 What Makes Vincerx Pharma (VINC) a New Buy Stock
10/07/24 Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates
08/21/24 Companies Like Vincerx Pharma (NASDAQ:VINC) Could Be Quite Risky
08/08/24 Vincerx Pharma Reports Second Quarter 2024 Financial Results
06/27/24 Vincerx Pharma (VINC) Moves to Buy: Rationale Behind the Upgrade
03:15 PM Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
04/25/24 Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
04/25/24 Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
04/09/24 Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
04/09/24 Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
04/08/24 Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
04/01/24 Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
03/29/24 Vincerx Pharma Inc (VINC) Reports Q4 and Full Year 2023 Financials: A Close Look
03/29/24 Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
08:38 AM 12 Most Profitable Biotech Stocks To Invest In
03/05/24 Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
03/05/24 Vincerx Pharma, Inc.'s (NASDAQ:VINC) large institutional owners must be happy as stock continues to impress, up 28% over the past week
01/07/24 Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
12/19/23 15 Best Falling Stocks To Buy Now
12/10/23 Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023
VINC Chatroom

User Image SwordfishTrader Posted - 4 hours ago

$VINC bullish if you’re buying at these levels. Not bullish if you’re bag holding at a much higher level. That’s the new reality.

User Image KidDynomike Posted - 7 hours ago

$SLS $VINC Damn homie—that was a harsh call out.

User Image JakeDelToro Posted - 7 hours ago

$SLS Always makes me laugh to see Billy The Kid Walker PhD esq. ( @telomerase ) lurking on the Sellas board with his same old Lindingo articles. The same guy who pumped $VINC from $.60 to $9 and then forgot to dump, and is now holding his $VINC shares at $.40. Sometimes bad things happen to good people. But in this case, it happened to the exact right person.

User Image Karthikmalini143 Posted - 9 hours ago

$VINC it will go again 0.70 don’t miss catch the train 🚂

User Image AVCT_PAID Posted - 10 hours ago

$VINC Even the bulls here sound like bears - time to sell it! I'll keep it on the watch list for a turn around someday.

User Image Yebin7777787 Posted - 15 hours ago

$VINC 스갤딥

User Image Yebin7777787 Posted - 2 days ago

$VINC 개잣같은거

User Image CON_or_McGregor Posted - 2 days ago

$VINC

User Image SwordfishTrader Posted - 3 days ago

$VINC added again today. Now 38k share swing with .44 avg.

User Image RamenLives Posted - 3 days ago

$VINC LFG.... Back to .70s

User Image jlemx Posted - 3 days ago

$VINC the CEO should make an agreement with a company that produces camptothecin-based chemotherapy drugs such as Irinotecan by PFE, proposing VIP236 as an alternative chemotherapy with very low impact. Chemotherapy is known to be effective and sometimes curative if it were not limited by its systemic toxicity. Hamdy you must immediately find the partner or the buyer.

User Image newTrader9999 Posted - 3 days ago

$VINC hamdy double dose of " dazed and confused" ... one in April 2nd one in October. Retail investors got slaughtered in both where the actual scientific news wasn't so bad at all and perhaps actually quite promising from all indications... yet the way Hamdy presented both data resulted in complete collapse of SP ... LEAVING HAMDY DAZED AND RETAIL BUTCHERED ... Nice.

User Image S_Franconi Posted - 3 days ago

$VINC From March. Early tests approach for Vincerx’s conjugate revolution https://www.oncologypipeline.com/apexonco/early-tests-approach-vincerxs-conjugate-revolution

User Image S_Franconi Posted - 3 days ago

$VINC Extremely oversold.

User Image S_Franconi Posted - 3 days ago

$VINC What Makes Vincerx Pharma (VINC) a New Buy Stock https://finance.yahoo.com/news/makes-vincerx-pharma-vinc-buy-160011148.html

User Image DHouston7 Posted - 3 days ago

$VINC https://x.com/onclive/status/1844710792018427980?s=46&t=NgWpnnnTHkzXuXYafv7twQ

User Image S_Franconi Posted - 3 days ago

$VINC If you talk about this ticker like it's a junk penny you will be blocked. No time for it. The news was really significant and important.

User Image jlemx Posted - 3 days ago

$VINC If vip236 achieved results comparable to those of chemo with camptothecin, but with very few side effects, how much would it be worth? Hamdy ,please, sell it.

User Image jlemx Posted - 3 days ago

$VINC How much would an offer be to buy Vincerx? How many times its current pitiful capitalization?

User Image Yebin7777787 Posted - 3 days ago

$VINC 잣같은

User Image CON_or_McGregor Posted - 3 days ago

$VINC it's over 😢

User Image RamenLives Posted - 4 days ago

$VINC Hopefully they have some masterful plan they will play to fix this....

User Image Karthikmalini143 Posted - 4 days ago

$VINC soon they going to do reverse split have to maintain the stock market standards I hope this will be down to .20 to .30 in between float then reverse split this is the only option they have to maintain stock price above 1$

User Image GreenTsunami Posted - 4 days ago

$VINC not worth my time or energy following or cheering a company led by a total incompetent moron CEO clown 🤡 and his BFF 🤡 the CFO. These two ruined the value and reputation of Vincerx and with zero partnerships that says a lot about their ability to be effective in the biotech business. This is my last post and deleting this ticker, lost so much money and I will never invest again in a biotech startup. Very disappointed.

User Image Biotech2424 Posted - 4 days ago

$CRBP Corbus looks cheap vast over reaction. Take a look at a similar ticker $CLRB they have a nda getting filed soon on their cancer drug could be billion dollar radiotherapy asset. Crbp went up initially on adc data had nothing to do with cb1. Total over reaction $VINC

User Image Restez Posted - 4 days ago

$VINC https://www.tradingview.com/news/zacks:f1d312295094b:0-what-makes-vincerx-pharma-vinc-a-new-buy-stock/

User Image regulator2000 Posted - 4 days ago

$VINC she's not done

User Image AVCT_PAID Posted - 4 days ago

@LabPsycho Yup - $VINC got me down 50% - not a happy camper!

User Image AVCT_PAID Posted - 4 days ago

$VINC Overall still bullish - but was NOT expecting to be down 50% on this stock.

User Image HoHoHoHum Posted - 4 days ago

$VINC $VINC it’s really chump change for BP’s to strike a partnership with VINC. It has nothing to do with macro conditions or inflation or whatever. Question is if they see it worth their while.

Analyst Ratings
Cantor Fitzgerald Overweight Apr 9, 24
Cantor Fitzgerald Overweight Apr 1, 24
Cantor Fitzgerald Overweight Sep 7, 23
Chardan Capital Buy Nov 17, 22
SVB Leerink Outperform Aug 12, 22
Cantor Fitzgerald Overweight Jun 8, 22
B. Riley Securities Buy Jun 7, 22
Chardan Capital Buy Jun 7, 22
SVB Leerink Outperform Jun 7, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hamdy Ahmed MD See Remarks See Remarks Aug 09 Buy 0.95 22,300 21,185 96,060 08/10/23
THOMAS TOM C See Remarks See Remarks Aug 10 Buy 0.95 5,000 4,750 219,935 08/10/23
Izumi Raquel E. See Remarks See Remarks Aug 09 Buy 0.92 16,476 15,158 85,214 08/10/23
Izumi Raquel E. See Remarks See Remarks Dec 14 Buy 0.8848 28,738 25,427 68,738 12/14/22
Hamdy Ahmed MD Chief Executive Offi.. Chief Executive Officer Dec 14 Buy 0.8656 35,280 30,538 73,760 12/14/22
THOMAS TOM C See Remarks See Remarks Dec 14 Buy 0.83 7,000 5,810 10,000 12/14/22
Hamdy Ahmed MD Chief Executive Offi.. Chief Executive Officer Jun 23 Buy 1.4106 24,200 34,137 38,480 06/27/22
Bushnell Laura I. Director Director Jun 09 Buy 1.9083 15,000 28,624 19,202 06/13/22